HC ANDERSEN CAPITAL

Main Menu

HC ANDERSEN CAPITAL

INDERES
CONTACT

Ascelia Pharma – Update on Q2 2024 and rights issue

AUTHOR
DATE
11. juli 2024
CATEGORY

Ascelia Pharma – Update on Q2 2024 and rights issue

Ascelia Pharma - Update on Q2 2024 and rights issue 19 AugustAug 2024 14:30 - 20 AugustAug 2024 15:00Online Event
Register

Information

Ascelia Pharma - Update on Q2 2024 and rights issue 19 AugustAug 2024 14:30 - 20 AugustAug 2024 15:00
Ascelia Pharma - Update on Q2 2024 and rights issue Online Event
Register

PREVIOUS STORY

NEXT STORY

Explore our services

IR Advisory

Read more

ESG Advisory

Read more

Legal Advisory

Read more

Corporate Finance

Read more

IR Recruitment

Read more

Certified Advisor (CA)

Read more

Commissioned Research

Read more

HCA Media

Read more

IR Distribution Software

Read more

AGM Services

Read more

IR Events

Read more

IR Websites

Read more

Digital IR

Read more

HC ANDERSEN CAPITAL

INFORMATION

Bredgade 23B 2. sal
1260 København K
View on map
Phone: 28 74 66 40
CVR: 41474793

About

What we do

HC Andersen Capital was established in 2020 and is at the forefront of digital Investor Relations, amplifying market presence.

Our tailored services encompass IR and ESG advisory, Legal Support, cutting-edge digital solutions such as IR websites and IR distribution software, Commissioned Research, Corporate Finance advisory and more. We are proudly Certified Advisor on Nasdaq First North Copenhagen.

2024 - HC Andersen Capital

Cookie Policy

Privacy Policy